Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Anti-Arrhythmic Drug Therapy
DRUG
3 trials
Sponsors
Biosense Webster EMEA
, Jason Andrade
, University of British Columbia
Conditions
Atrial Fibrillation
Phase 3
FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)
Completed
NCT00137540
Biosense Webster EMEA
Atrial Fibrillation
Start: 2005-09-30
End: 2008-07-31
Updated: 2025-02-03
Unknown Phase
Early Aggressive Invasive Intervention for Atrial Fibrillation
NCT02825979
Jason Andrade
Atrial Fibrillation
Start: 2017-01-31
End: 2022-11-30
Updated: 2022-10-10
The Impact of First-Line Rhythm Therapy on AF Progression
NCT05514860
University of British Columbia
Atrial Fibrillation
Start: 2017-01-31
End: 2022-11-30
Updated: 2022-10-10
Related Papers
The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial Fibrillation.
2023-11-23
6 citations
An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective
European Heart Journal
2023-11-01
2 citations
An economic evaluation of first-line cryoballoon ablation vs antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a U.S. Medicare perspective
Heart Rhythm O2
2023-07-27
13 citations
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy
New England Journal of Medicine
2022-11-07
326 citations
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
New England Journal of Medicine
2020-11-16
732 citations
A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.
2018-10-18
26 citations